SD BioSensor, Inc

A137310

KR7137310009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
10,540 ^KRW	+0.48%		+4.46%	-7.87%

2023	SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	CI
2023	SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	CI

South Korean consortium to buy Meridian Bioscience in $1.53 billion deal

July 07, 2022 at 07:36 am EDT

(Reuters) - Meridian Bioscience Inc said on Thursday it had agreed to be acquired by South Korea-based SD Biosensor Inc and SJL Partners LLC in an all-cash $1.53-billion deal.

(Reporting by Leroy Leo in Bengaluru; Editing by Vinay Dwivedi)

Latest news about SD BioSensor, Inc

SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	23-07-27	CI
SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	23-07-26	CI
Columbus Holding Company announced that it has received KRW 258.2251644 billion in funding from SD Biosensor, Inc	23-06-27	CI
Columbus Holding Company announced that it expects to receive KRW 258.2251644 billion in funding from SD Biosensor, Inc	23-06-12	CI
SD Biosensor, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
SD Biosensor, Inc. Proposes Discontuation of Use and Disposal of Specific Pilot COVID-19 At-Home Tests in the United States Due to Microbial Contamination in the Liquid Disposal Solution	23-05-04	CI
SD Biosensor, SJL Partners Acquire Meridian Bioscience	23-01-31	MT
SD BioSensor, Inc and SJL Partners completed the acquisition of Meridian Bioscience, Inc. from Impactive Capital LP, BlackRock, Inc., The Vanguard Group, Inc, Royce & Associates, LP and others.	23-01-30	CI
DoubleVerify Holdings to Replace Meridian Bioscience in S&P SmallCap 600	23-01-26	MT
Roche teams up with Pfizer on COVID-19 awareness campaign	22-12-14	RE
Meridian Bioscience Says Closing Date of Pending Merger With SD Biosensor, Others Pushed Back to Jan. 31	22-12-12	MT
Meridian Bioscience Fiscal Q4 Adjusted EPS, Revenue Decline	22-11-22	MT
SD Biosensor Records 67% Jump in Q3 Profit; Shares Up 4%	22-11-04	MT
SD Biosensor to Supply $112.3 Million in COVID-19 Test Kits to Japan	22-08-19	MT
South Korean Stocks Fall for Third Straight Day as Uncertainties Linger Around US Fed’s Rate Hikes Ahead; SD Biosensor Loses 2%	22-08-19	MT
Meridian Bioscience Posts Decline in Fiscal Q3 Adjusted Net Earnings, Higher Revenue, Scraps 2022 Guidance	22-08-05	MT
SD Biosensor's Net Income Jumps 18% in June Quarter	22-08-03	MT
SD Biosensor to Take Over Ohio-based Meridian Bioscience for $1.53 Billion	22-07-11	MT
Maeil Broadcasting Network announced that it has received KRW 1.8000081 billion in funding from Bubang Co., Ltd., Hansae Co., Ltd., SD Biosensor, Inc, Nmedia Co., Ltd., HANSHIN Engineering & Construction Co., Ltd., Ex-In Housing Co., Ltd.	22-07-07	CI
South Korean firms to take Meridian Bioscience private in $1.53 bln deal	22-07-07	RE
Meridian Bioscience Reports Fiscal Q3 Preliminary Revenue; Shares Halted on Acquisition News	22-07-07	MT
South Korean consortium to buy Meridian Bioscience in $1.53 billion deal	22-07-07	RE
Maeil Broadcasting Network announced that it expects to receive KRW 1.8000081 billion in funding from Bubang Co., Ltd., Hansae Co., Ltd., SD BioSensor, Inc, Nmedia Co., Ltd., HANSHIN Engineering & Construction Co., Ltd., Ex-In Housing Co., Ltd. and another investor	22-06-21	CI
SD BioSensor, Inc(KOSE:A137310) added to KOSPI 200 Index	22-06-10	CI
SD Biosensor to Buy Italian Medical Device Distributor for 50 Million	22-04-24	MT

SD Biosensor Inc is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for SD BioSensor, Inc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

10,540 KRW

Average target price

10,000 KRW

Spread / Average Target

-5.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
SD BIOSENSOR, INC	-7.87%	952M
BIOMÉRIEUX	-1.89%	12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.68B
DIASORIN S.P.A.	-1.31%	5.29B
LANTHEUS HOLDINGS, INC.	+21.82%	5.18B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-50.89%	3.29B
ANDON HEALTH CO., LTD.	+6.42%	2.6B
VITROLIFE AB	-10.02%	2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B

Diagnostic & Testing Substances

SD BioSensor, Inc

Equities

A137310

KR7137310009

Medical Equipment, Supplies & Distribution

South Korean consortium to buy Meridian Bioscience in $1.53 billion deal

Latest news about SD BioSensor, Inc

Chart SD BioSensor, Inc

Company Profile

Income Statement Evolution

Ratings for SD BioSensor, Inc

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Diagnostic & Testing Substances